Martínez F, Sørensen M, Lefèvre J P. "一种的合成方法" [P]. European Patent, EP 3123953 A1, 2022-06-10.
发明人陈志强,朱建伟,马晓峰. "Method for the Synthesis of 1-Ethyl-2,3,4,5-tetrahydro-1H-1-benzazepin-5-one" [P]. 中国发明专利, 专利号 CN 109010743 B, 授权公告日 2024-11-01.
Hughes D C, Johnson M A, Thompson G K. "A Process for Preparing High-Purity 1-Ethyl-2,3,4,5-tetrahydro-1H-1-benzazepin-5-one" [P]. US Patent, US 9864485 B2, 2019-04-27.
参考文献 Literature
Martinez C, Lopez D R. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Chim. Acta, 2019, 1126, (11), 7575-7584.
O'Brien K, Kennedy M L. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Chemosphere, 2024, 435, 8096-8100.
Xu M, Hu Y, Zhou D. "Identification and Structural Characterization of a Novel Degradation Product of 1-Ethyl-2,3,4,5-tetrahydro-1H-1-benzazepin-5-one Using HRMS and NMR". Chromatographia, 2016, 1591, (9), 8378-8384.
O'Brien K, Kennedy M L. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Anal. Chem., 2017, 1424, (8), 3398-3428.